SymBio Pharmaceuticals News

SymBio Pharmaceuticals: Change report.

Jul 25 02:23 ET

SymBio Pharmaceuticals: Notice regarding confirmation of the details of the issuance of stock acquisition rights (stock options) to be issued to our employees

Apr 19 04:10 ET

SymBio Pharmaceuticals: Notice regarding determination of the details of the issuance of stock acquisition rights (stock options) to be issued to our directors

Apr 19 04:10 ET

SymBio Pharmaceuticals: Notice of completion of payment for new stock issuance (5th allotment) through third-party allotment based on the Comprehensive Stock Issuance Program (“STEP”) establishment agreement

Apr 18 21:00 ET

Synbio Pharmaceuticals: Notice Concerning Exercise Price Adjustments

Apr 3 02:30 ET

Synbio Pharmaceutical: Determination of issuance conditions for new stock issuance (5th allotment) through third party allotment based on a comprehensive stock issuance program establishment agreement and changes in the amount of funds raised through the new share issuance (5th allocation)

Apr 3 02:30 ET

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Apr 3 02:05 ET

SymBio Pharmaceuticals: Corrected securities registration form (reference method)

Mar 25 00:07 ET

SymBio Pharmaceuticals: Notice regarding issuance of stock acquisition rights (stock options) to our employees

Mar 22 04:45 ET

SymBio Pharmaceuticals: Notice regarding the issuance of stock acquisition rights (stock options) to our directors

Mar 22 04:45 ET

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Mar 22 02:50 ET

SymBio Pharmaceuticals: Notice of completion of payment for new stock issuance (4th allotment) through third-party allotment based on the Comprehensive Stock Issuance Program (“STEP”) establishment agreement

Mar 17 21:00 ET

Synbio Pharmaceuticals: Notice Concerning Exercise Price Adjustments

Feb 29 02:30 ET

Synbio Pharmaceutical: Determination of issuance conditions for new stock issuance (4th allotment) through third-party allotment based on a comprehensive share issuance program establishment agreement and change in the amount of funds raised through the ne

Feb 29 02:30 ET

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 29 02:07 ET

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 29 02:06 ET

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 22 01:57 ET

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 22 01:55 ET

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 8 02:16 ET

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 8 02:14 ET